annual working capital:
$544.24M+$209.94M(+62.80%)Summary
- As of today (July 1, 2025), PTGX annual working capital is $544.24 million, with the most recent change of +$209.94 million (+62.80%) on December 31, 2024.
- During the last 3 years, PTGX annual working capital has risen by +$247.52 million (+83.42%).
- PTGX annual working capital is now at all-time high.
Performance
PTGX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$570.75M+$26.50M(+4.87%)Summary
- As of today (July 1, 2025), PTGX quarterly working capital is $570.75 million, with the most recent change of +$26.50 million (+4.87%) on March 1, 2025.
- Over the past year, PTGX quarterly working capital has dropped by -$16.89 million (-2.88%).
- PTGX quarterly working capital is now -2.88% below its all-time high of $587.64 million, reached on March 31, 2024.
Performance
PTGX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
PTGX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.8% | -2.9% |
| 3 y3 years | +83.4% | +91.5% |
| 5 y5 years | +395.2% | +536.9% |
PTGX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.8% | -2.9% | +169.3% |
| 5 y | 5-year | at high | +395.2% | -2.9% | +244.7% |
| alltime | all time | at high | +6255.8% | -2.9% | +5051.2% |
PTGX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $570.75M(+4.9%) |
| Dec 2024 | $544.24M(+62.8%) | $544.24M(+25.9%) |
| Sep 2024 | - | $432.19M(-18.4%) |
| Jun 2024 | - | $529.35M(-9.9%) |
| Mar 2024 | - | $587.64M(+75.8%) |
| Dec 2023 | $334.30M(+57.8%) | $334.30M(+12.6%) |
| Sep 2023 | - | $297.01M(+2.2%) |
| Jun 2023 | - | $290.54M(+36.7%) |
| Mar 2023 | - | $212.51M(+0.3%) |
| Dec 2022 | $211.90M(-28.6%) | $211.90M(-11.7%) |
| Sep 2022 | - | $239.86M(-9.2%) |
| Jun 2022 | - | $264.21M(-11.4%) |
| Mar 2022 | - | $298.07M(+0.5%) |
| Dec 2021 | $296.72M(+7.8%) | $296.72M(+2.8%) |
| Sep 2021 | - | $288.53M(-12.3%) |
| Jun 2021 | - | $328.85M(+31.0%) |
| Mar 2021 | - | $250.99M(-8.9%) |
| Dec 2020 | $275.37M | $275.37M(+66.3%) |
| Sep 2020 | - | $165.59M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $182.11M(+103.2%) |
| Mar 2020 | - | $89.61M(-18.5%) |
| Dec 2019 | $109.91M(-1.3%) | $109.91M(-3.0%) |
| Sep 2019 | - | $113.25M(+8.9%) |
| Jun 2019 | - | $104.00M(+5.6%) |
| Mar 2019 | - | $98.50M(-11.5%) |
| Dec 2018 | $111.34M(+2.7%) | $111.34M(-9.8%) |
| Sep 2018 | - | $123.40M(+15.2%) |
| Jun 2018 | - | $107.09M(-1.1%) |
| Mar 2018 | - | $108.31M(-0.1%) |
| Dec 2017 | $108.39M(+41.1%) | $108.39M(+138.4%) |
| Sep 2017 | - | $45.46M(-23.9%) |
| Jun 2017 | - | $59.76M(-0.0%) |
| Mar 2017 | - | $59.77M(-22.2%) |
| Dec 2016 | $76.81M(+593.2%) | $76.81M(-20.7%) |
| Sep 2016 | - | $96.90M(+429.3%) |
| Jun 2016 | - | $18.31M(-30.8%) |
| Mar 2016 | - | $26.47M(+138.9%) |
| Dec 2015 | $11.08M(+29.4%) | $11.08M |
| Dec 2014 | $8.56M | - |
FAQ
- What is Protagonist Therapeutics annual working capital?
- What is the all time high annual working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual working capital year-on-year change?
- What is Protagonist Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly working capital year-on-year change?
What is Protagonist Therapeutics annual working capital?
The current annual working capital of PTGX is $544.24M
What is the all time high annual working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual working capital is $544.24M
What is Protagonist Therapeutics annual working capital year-on-year change?
Over the past year, PTGX annual working capital has changed by +$209.94M (+62.80%)
What is Protagonist Therapeutics quarterly working capital?
The current quarterly working capital of PTGX is $570.75M
What is the all time high quarterly working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly working capital is $587.64M
What is Protagonist Therapeutics quarterly working capital year-on-year change?
Over the past year, PTGX quarterly working capital has changed by -$16.89M (-2.88%)